Joon Lee
Stock Analyst at Truist Securities
(4.74)
# 121
Out of 5,090 analysts
114
Total ratings
59.82%
Success rate
41.38%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALKS Alkermes | Maintains: Buy | $50 → $55 | $29.52 | +86.31% | 3 | Nov 17, 2025 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $25 → $14 | $9.61 | +45.68% | 5 | Nov 10, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $100 → $90 | $36.38 | +147.39% | 1 | Nov 5, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $90 → $80 | $53.40 | +49.81% | 3 | Oct 28, 2025 | |
| PRAX Praxis Precision Medicines | Reiterates: Buy | $85 → $360 | $247.99 | +45.17% | 6 | Oct 17, 2025 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $44 | $29.50 | +49.15% | 1 | Sep 16, 2025 | |
| ARGX argenx SE | Maintains: Buy | $700 → $918 | $901.17 | +1.87% | 13 | Sep 15, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $520 → $490 | $455.48 | +7.58% | 4 | Aug 5, 2025 | |
| PTCT PTC Therapeutics | Maintains: Buy | $80 → $86 | $77.26 | +11.32% | 2 | Jul 29, 2025 | |
| VKTX Viking Therapeutics | Reiterates: Buy | $95 → $75 | $38.55 | +94.55% | 8 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $21 | $12.79 | +64.19% | 6 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $76 → $150 | $86.11 | +74.21% | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $200 | $149.22 | +34.03% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $120 | $56.88 | +110.97% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.70 | +386.49% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.77 | +177.30% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $36 | $7.49 | +380.64% | 3 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $23.53 | +53.00% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $2.42 | +230.58% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $10.56 | +60.98% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $40 | $4.26 | +838.97% | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $169.70 | +17.86% | 2 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $5.05 | -0.99% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $4.28 | +320.56% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $1.68 | +16,566.67% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $44.41 | -23.44% | 1 | Mar 16, 2021 |
Alkermes
Nov 17, 2025
Maintains: Buy
Price Target: $50 → $55
Current: $29.52
Upside: +86.31%
Intellia Therapeutics
Nov 10, 2025
Reiterates: Buy
Price Target: $25 → $14
Current: $9.61
Upside: +45.68%
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $100 → $90
Current: $36.38
Upside: +147.39%
BioMarin Pharmaceutical
Oct 28, 2025
Maintains: Buy
Price Target: $90 → $80
Current: $53.40
Upside: +49.81%
Praxis Precision Medicines
Oct 17, 2025
Reiterates: Buy
Price Target: $85 → $360
Current: $247.99
Upside: +45.17%
Rapport Therapeutics
Sep 16, 2025
Initiates: Buy
Price Target: $44
Current: $29.50
Upside: +49.15%
argenx SE
Sep 15, 2025
Maintains: Buy
Price Target: $700 → $918
Current: $901.17
Upside: +1.87%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $520 → $490
Current: $455.48
Upside: +7.58%
PTC Therapeutics
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $77.26
Upside: +11.32%
Viking Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $38.55
Upside: +94.55%
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $12.79
Upside: +64.19%
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $86.11
Upside: +74.21%
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $149.22
Upside: +34.03%
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $56.88
Upside: +110.97%
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $3.70
Upside: +386.49%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $5.77
Upside: +177.30%
Nov 12, 2024
Maintains: Buy
Price Target: $17 → $36
Current: $7.49
Upside: +380.64%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $23.53
Upside: +53.00%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $2.42
Upside: +230.58%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $10.56
Upside: +60.98%
Aug 14, 2024
Maintains: Buy
Price Target: $60 → $40
Current: $4.26
Upside: +838.97%
Mar 20, 2024
Reiterates: Buy
Price Target: $200
Current: $169.70
Upside: +17.86%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $5.05
Upside: -0.99%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $4.28
Upside: +320.56%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $1.68
Upside: +16,566.67%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $44.41
Upside: -23.44%